ProQR Therapeutics (PRQR) EPS (Weighted Average and Diluted) (QoQ) (2017 - 2025)
ProQR Therapeutics (PRQR) EPS (Weighted Average and Diluted) (QoQ) (2017 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
| 10 |
ProQR Therapeutics |
7.70 Mn |
-99.88 Mn |
- |
| Date | Value |
|---|
| Dec 31, 2025 |
100.00% |
| Sep 30, 2025 |
43.72% |
| Jun 30, 2025 |
41.39% |
| Mar 31, 2025 |
-97,740,423.54% |
| Dec 31, 2024 |
100.00% |
| Sep 30, 2024 |
-78.15% |
| Jun 30, 2024 |
75.66% |
| Mar 31, 2024 |
-139,650,897.70% |
| Dec 31, 2023 |
100.00% |
| Sep 30, 2023 |
43.28% |
| Jun 30, 2023 |
54.25% |
| Mar 31, 2023 |
-44,826,226.06% |
| Dec 31, 2022 |
100.00% |
| Sep 30, 2022 |
7.81% |
| Jun 30, 2022 |
50.20% |
| Mar 31, 2022 |
-271.68% |
| Dec 31, 2021 |
11.70% |
| Sep 30, 2021 |
35.05% |
| Jun 30, 2021 |
34.37% |
| Mar 31, 2021 |
-249.39% |
